[Veco Cup] As a technology participant in the "Veco Cup OFweek 2023 China Robotics Industry Annual Investment Value Enterprise Award"

OFweek Cup · OFweek 2023 China Robot Industry Annual Selection (abbreviated as OFweek Robot Awards 2023) is jointly organized by OFweek, China's high-tech industry portal, and its authoritative robot professional media - OFweek Robot. This selection is a major brand event in China's robot industry and one of the most professional and influential selections in the high-tech industry.

The event aims to build a brand communication and display platform for products, technologies and companies in the robotics industry, and leverage the resources and influence of the OFweek platform to promote innovative products and solutions to industry users and the market, encouraging more companies to invest in technological innovation; at the same time, it will deliver more innovative products and cutting-edge technologies to the industry, and together imagine the future of the robotics industry.

The OFweek Robot Awards 2023, the annual selection of China's robot industry, will enter the online voting stage from February 20 to March 20, 2024, and the award ceremony will be held in Shenzhen on April 18. At present, the event is in the hot stage of enterprise application, and enterprises in the industry have responded positively.

As a technology participant in the "Veco Cup OFweek 2023 China Robotics Industry Annual Investment Value Enterprise Award"

Award: Veken Cup OFweek 2023 China Robotics Industry Annual Investment Value Enterprise Award

Participating companies: Shenzhen Zuowei Technology Co., Ltd.

Company Introduction:

Founded in 2019, the company is a national high-tech enterprise integrating R&D, design, manufacturing, sales and services. It focuses on the intelligent care of disabled elderly people, provides comprehensive solutions of intelligent care equipment and smart care platform around the six care needs of disabled elderly people, and is committed to becoming a high-quality service provider in the intelligent care industry.

The company currently has 150 employees, including 30 in the R&D team. Its main revenue in 2023 will exceed 80 million yuan. Its sales channels cover the whole country, and its products are exported to more than 30 countries and regions including Europe, America, Japan and South Korea.

The company has independently developed more than 20 intelligent nursing products in five series around the six nursing needs of the disabled, obtained more than 200 knowledge products, passed seven management system certifications, and obtained FDA, CE, CQC and other important domestic and foreign qualification certifications; the main operating income in 2022 was 40 million yuan, which increased to more than 80 million yuan in 2023, with a growth rate of more than 200%; in 2022, it obtained an investment of 60 million yuan led by Beijing Dachen, a leading investment company in China, and in 2023, it obtained an investment of 100 million yuan led by Shenzhen Investment Control Donghai; in 2022, it was recognized as a national high-tech enterprise, and in 2023 it was recognized as a specialized and new small and medium-sized enterprise in Shenzhen. The intelligent nursing robot project won the second prize and the excellence award in the 13th and 15th Shenzhen Entrepreneurship Competition, and won the gold medal in the 2023 Guangdong Province "Chongchuang Cup" Entrepreneurship Competition and the 2023 Ministry of Industry and Information Technology Smart Health Application Pilot Demonstration Enterprise; the Shenzhen Branch of Shanghai Rehabilitation Equipment Engineering Technology Center was established, and Professor Yu Hongliu of Shanghai University of Technology was hired as the chief scientist to jointly build the "Hunan Engineering Research Center for Smart Medical Care" with Central South University.

Reasons for participation:

1. The industry in which the project is located is in line with the national strategy and belongs to a sunrise industry with broad market prospects at home and abroad. China has become the country with the largest number of disabled elderly people in the world. "Actively responding to population aging" and "smart elderly care" have been promoted to national strategies, and the "technology + elderly care" track has broad prospects. By 2025, the market demand for nursing equipment in hospitals and elderly care institutions has reached about 20 billion yuan, of which the demand for secondary public hospitals is about 6 billion yuan, and the demand for 40,000 nursing homes across the country is about 12 billion yuan. At the same time, there are currently 120 million disabled people overseas, and the global market size is in the hundreds of billions of US dollars.

2. The project products directly meet the "hard needs" of disabled families and nursing institutions. There are 44 million disabled and semi-disabled elderly people in China, and on average there is one disabled or semi-disabled elderly person in every 10 families. Many of these families face the dilemma of "one person is disabled, the whole family is unbalanced". At the same time, there is a large shortage of nursing staff and serious loss. Due to the shortage of staff and high operating costs, it is difficult for disabled elderly care institutions to retain staff and make money. The products of this project can replace manual labor to complete heavy nursing work, effectively reduce the burden of elderly care on families and society, directly meet their hard needs, and effectively resolve the pressure on families and nursing institutions caused by the difficulty of nursing disabled elderly people and the serious shortage of nursing staff.

3. The project founders and R&D team are experienced. The project founding team is composed of a group of executives and R&D teams from Fortune 500 companies, and has accumulated rich work experience in artificial intelligence, medical devices, clinical medicine transformation and other fields. The founder and actual controller of the company graduated from Lincoln University, with a Ph.D. in Economics, EMBA from Cheung Kong Graduate School of Business, MBA, information engineer, and psychological counselor. He has been intensively cultivating the medical and health field for more than 10 years, and has accumulated rich experience in corporate strategic planning, corporate management, technology transformation, product matrix, marketing, etc. He is a continuous successful entrepreneur with not only a deep professional background, but also a keen sense of the market. The company has always been able to achieve "double prominence" in R&D and market. In just 4 years since its establishment, the company has completed product development and mass production for five of the six disability indicators, and has obtained and is applying for as many as 97 invention patents. In 2022, it was recognized as a national science and technology-based small and medium-sized enterprise and a national high-tech enterprise.

4. The project product technology is mature and reliable. The series of products for urination, defecation, bathing, getting in and out of bed, and walking have obtained important domestic and foreign certifications such as the FDA medical device certification and CE in the United States and Europe. The main product, urination and defecation , intelligent robot, is a domestic first. The relevant technology is synchronized with the international eighth-generation technology, surpassing Japan's native generation products, and is 2-3 generations higher than similar domestic products. The product series has excellent performance and high cost performance. It has been widely used in rehabilitation hospitals and nursing homes across the country and has received good reviews.

Voting time:

The voting for this year's "OFweek Robot Awards 2023" event will begin on February 20. Please pay attention to the robot-related selection news on Veken.com and you are welcome to vote.